AbbVie Inc. Deferred Income Tax 2011-2026 | ABBV
Beta
What is deferred income tax?
Deferred income tax represents the difference between income tax expense recognized on the income statement and the actual tax liability paid.
What is AbbVie Inc.'s current deferred income tax?
AbbVie Inc. (ABBV) annual deferred income tax for 2025 was $-492.0M, a 66.05% increase from 2024. AbbVie Inc. deferred income tax for the quarter ending March 31, 2026 was $137.0M.
What was AbbVie Inc.'s deferred income tax in 2024?
AbbVie Inc. annual deferred income tax for 2024 was $-1.45B, a 49.84% increase from 2023.
What was AbbVie Inc.'s deferred income tax in 2023?
AbbVie Inc. annual deferred income tax for 2023 was $-2.89B, a 49.61% decline from 2022.
Deferred Income Tax History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-2.33B
→
FY2025
$-492.0M
111213141516171819202122232425
5 years selected
Deferred Income Tax History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-492.0M | +66.0% | 10-K |
| FY2024 | $-1.45B | +49.8% | 10-K |
| FY2023 | $-2.89B | -49.6% | 10-K |
| FY2022 | $-1.93B | -115.0% | 10-K |
| FY2021 | $-898.0M | +61.4% | 10-K |
| FY2020 | $-2.33B | -2005.7% | 10-K |
| FY2019 | $122.0M | +108.0% | 10-K |
| FY2018 | $-1.52B | +63.6% | 10-K |
| FY2017 | $-4.16B | -422.9% | 10-K |
| FY2016 | $-796.0M | -623.7% | 10-K |
| FY2015 | $152.0M | +140.0% | 10-K |
| FY2014 | $-380.0M | -160.9% | 10-K |
| FY2013 | $624.0M | +500.0% | 10-K |
| FY2012 | $104.0M | +131.3% | 10-K |
| FY2011 | $-332.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →